Tandem Clinical Research GI, LLC

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)5 trials
• Obesity2 trials
• High blood pressure1 trial
• Irritable bowel syndrome1 trial
• Liver cirrhosis1 trial

Phase

• Phase 28 trials
• Phase 11 trial

Status

• Completed6 trials
• Terminated2 trials
• Recruiting1 trial

Lead sponsor

• CinPhloro Pharma, LLC1 trial
• Eccogene1 trial
• Gilead Sciences1 trial
• Ionis Pharmaceuticals, Inc.1 trial
• Kardigan, Inc.1 trial
• and 4 more

Running trials

• Recruiting

  A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

  NCT07288138· Phase 2· Eccogene· Source

  Contact: Eccogene Clinical Trials

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)1 recruiting

Closed trials

• Completed

  A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)

  NCT06864104· Phase 2· Kardigan, Inc.· Source

• Completed

  Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese

  NCT06445075· Phase 2· Scholar Rock, Inc.· Source

• Completed

  A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

  NCT06299098· Phase 2· Regeneron Pharmaceuticals· Source

• Terminated

  Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

  NCT06153420· Phase 2· CinPhloro Pharma, LLC· Source

• Terminated

  A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4

  NCT07052682· Phase 1· Takeda· Source

• Completed

  Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

  NCT04971785· Phase 2· Gilead Sciences· Source

• Completed

  A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224

  NCT04932512· Phase 2· Ionis Pharmaceuticals, Inc.· Source

• Completed

  Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

  NCT04321031· Phase 2· Pfizer· Source